Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Ideally, all patients with advanced cancers would be in clinical trials. Until then, the right to try is an option we all should have.

Right to Try bills attack the one agency tasked with verifying the safety and efficacy of medications.

Ryan Clary, executive director of the National Viral Hepatitis Roundtable, sits at the helm of U.S. efforts to end the epidemic.

A recent study found that daily cannabis use was associated with a reduced risk of the liver condition in this population.

The yearlong effort, “#StigmaStops,” launches on Zero Discrimination Day, March 1. Here’s how you can get involved.

In the last two decades, liver cancer deaths have increased by 80%, making it one of the fastest-growing causes of cancer deaths worldwide.

A recent study in mice found that a high dose of green tea extract had a beneficial effect on a new sign of liver cancer progression.

A joint statement from the Infectious Diseases Society of America and the HIV Medicine Association to President Trump and Congress.

Studies suggest it reduces the risk of liver cancer—and possibly other types as well.